Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1+/− Mice

Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1+/− Mice

Atorvastatin is widely used to lower blood cholesterol and to reduce risk of cardiovascular disease–associated complications. Epidemiological investigations and preclinical studies suggest that statins such as atorvastatin have antitumor activity for various types of cancer. Tuberous sclerosis (TSC)...

Full description

Bibliographic Details
Main Authors:	Ming Hong Shen, Paulina Samsel, Louise L. Shen, Kalin Narov, Jian Yang, Julian R. Sampson
Format:	Article
Language:	English
Published:	Elsevier 2017-10-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523317300761

Similar Items

Combination of everolimus with sorafenib for solid renal tumors in Tsc2+/- mice is duperior to everolimus alone
by: Yang, J, et al.
Published: (2017)

A brain proteomic investigation of rapamycin effects in the Tsc1 +/− mouse model
by: Hendrik Wesseling, et al.
Published: (2017-08-01)

Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin
by: Robert P. Carson, et al.
Published: (2012-01-01)

MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM).
by: Anil J Trindade, et al.
Published: (2013-01-01)

Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain
by: Rebecca L. Cox, et al.
Published: (2018-11-01)

Comparison of three rapamycin dosing schedules in A/J <it>Tsc2</it><sup>+/- </sup>mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors
by: Dabora Sandra L, et al.
Published: (2010-02-01)

Sodium hydroxide enhances the efficacy of rapamycin to suppress proliferation of Tsc2-null mouse embryonic fibroblasts
by: LI Kai, WANG Ya-nan
Published: (2021-07-01)

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells.
by: Blanca E Himes, et al.
Published: (2018-01-01)

Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice
by: Ancy Thomas, et al.
Published: (2021-11-01)

Tumor suppressors TSC1 and TSC2 differentially modulate actin cytoskeleton and motility of mouse embryonic fibroblasts.
by: Elena A Goncharova, et al.
Published: (2014-01-01)

Identification of a region required for TSC1 stability by functional analysis of <it>TSC1 </it>missense mutations found in individuals with tuberous sclerosis complex
by: den Dunnen Johan T, et al.
Published: (2009-09-01)

Correction: Tumor suppressors TSC1 and TSC2 differentially modulate actin cytoskeleton and motility of mouse embryonic fibroblasts.
by: PLOS ONE Staff
Published: (2015-01-01)

Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
by: Wen Liu, et al.
Published: (2019-05-01)

Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing.
by: Magdalena E Tyburczy, et al.
Published: (2015-11-01)

Evidence for population variation in <it>TSC1 </it>and <it>TSC2 </it>gene expression
by: Saffen David, et al.
Published: (2011-02-01)

TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling
by: Pauline Martin, et al.
Published: (2020-01-01)

Effect of Atorvastatin on Memory in Albino Mice
by: RINKU RANI BISWAS, et al.
Published: (2014-11-01)

Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
by: Matthew Tunbridge, et al.
Published: (2022-09-01)

Longitudinal imaging studies of tumor microenvironment in mice treated with the mTOR inhibitor rapamycin.
by: Keita Saito, et al.
Published: (2012-01-01)

Functional characterisation of the TSC1–TSC2 complex to assess multiple <it>TSC2 </it>variants identified in single families affected by tuberous sclerosis complex
by: Dommering Charlotte, et al.
Published: (2008-02-01)

Therapeutic Effect of Rapamycin on Aortic Dissection in Mice
by: Makiko Hayashi-Hori, et al.
Published: (2020-05-01)

Rapamycin rejuvenates oral health in aging mice
by: Jonathan Y An, et al.
Published: (2020-04-01)

Rapamycin attenuates ioversol-induced acute kidney injury in rat models
by: LI Qingju, YU Ran, CHEN Jiajia, CHEN Haoyu, SONG Jian, WANG Wanpeng
Published: (2024-01-01)

Exceptional response to neoadjuvant capecitabine and temozolomide in TSC2-mutant pancreatic neuroendocrine tumor
by: Robin Park, et al.
Published: (2020-12-01)

An overview of actionable and potentially actionable TSC1 and TSC2 germline variants in an online Database
by: Arthur Bandeira de Mello Garcia, et al.
Published: (2024-02-01)

Immunomodulatory effects of atorvastatin on MRL/lpr mice
by: Jing Sun, et al.
Published: (2022-12-01)

Biosynthesis of rapamycin by streptomyces hygroscopicus
by: Paiva, Nancy L. (Nancy Louise)
Published: (2005)

Development of Microcomputer-controlled TSC Arc Suppression Coil
by: PAN Ming-fu
Published: (2011-09-01)

TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
by: Clévia Rosset, et al.

Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex.
by: Arthur Jorge Santiago Lima, et al.
Published: (2014-01-01)

Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis.
by: Clévia Rosset, et al.
Published: (2017-01-01)

Moderate lifelong overexpression of tuberous sclerosis complex 1 (TSC1) improves health and survival in mice
by: Hong-Mei Zhang, et al.
Published: (2017-04-01)

Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.
by: Peng Nie, et al.
Published: (2014-01-01)

Rapamycin alleviates hepatocellular carcinoma progressing in transgenic mice
by: LIN Yingxue, CUI Haipeng, WANG Aiguo, YAO Yinhui, ZHAO Juan
Published: (2023-08-01)

Rapamycin Ameliorates Radiation-Induced Testis Damage in Mice
by: Juan Yang, et al.
Published: (2022-04-01)

The Possible Cellular Mechanism for Extending Lifespan of Mice with Rapamycin
by: Li Shulin
Published: (2009-09-01)

The Possible Cellular Mechanism for Extending Lifespan of Mice with Rapamycin
by: Li Shulin
Published: (2009-01-01)

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Colhoun, H, et al.
Published: (2009)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
by: Rita Leal, et al.
Published: (2018-03-01)

Tsc2 coordinates neuroprogenitor differentiation
by: Victoria A. Riley, et al.
Published: (2023-12-01)